JetEquities

Chembio Diagnostics Awarded BARDA Contract for Development of DP

Long
NASDAQ:CEMI   None
CEMI: Chembio Diagnostics, Inc.
2020-07-06 16:10:10
Chembio Diagnostics Awarded BARDA Contract for Development of DPP COVID-19 Point-of-Care Antigen System
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.